InvestSMART

Shield Therapeutics PLC (LON: STX) - Share Price

Current share price for STX : 4.200p 0.25 (6.33%)+

Currency: GBX (p)

Shield Therapeutics PLC is a commercial-stage specialty pharmaceutical company that delivers ACCRUFeR/FeRACCRU (ferric maltol) is an ASX-listed company and is not held by any exchange traded funds (ETFs). It , a differentiated pharmaceutical product, to address the unmet need for patients suffering from iron deficiency,with or without anemia. The company has launched ACCRUFeR in the U.S. Outside of the U.S., it has licensed the rights to specialty pharmaceutical companies. FeRACCRU is commercialised in the UK, the European Union, and Canada, with marketing rights in Australia and New Zealand. The company's operating segments are: FeRACCRU, which generates the maximum revenue, and PT20. Geographically, it generates maximum revenue from the U.S., and the rest from the Netherlands, Canada, Japan, and South Korea.

STX General Information +

LON Code STX
Industry/Sector Drug Manufacturers - Specialty & Generic
Market Cap (£M) 4,487
STX Share Price 4.200p
Day High 4.300p
Day Low 3.900p
Last Close 3.950p
STX Share Price Movement 0.25p ( 6.33% )
Prices as at 17:30, 12 Aug 2026
+Security prices are at best end-of-day and are indicative only.

STX Financial Summary

Operating Revenue Per Share Price to Operating revenue Price to free cash flow Earnings Yield PE Ratio Dividend Yield Forward Dividend Yield Forward Earnings Yield
0.59p 7.08p -1,617.31p 3.11% 32.15 n/a n/a 0.48

STX Calendar of Events

Created Date Changed Date Event
n/a n/a n/a

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.